Great Basin Corp. has announced it has received FDA 510(k) clearance for its molecular diagnostic test for Clostridium difficile, according to a news release (pdf).
The Latest
Colorado is among the most recent states debating the rights of certified nurse anesthetists to administer anesthesia without a physician's supervision, according to a New York Times report.
Anesthesia Business Consultants yesterday announced integration with Epic Anesthesia at Greenwich Hospital in Greenwich, Conn.
Access MediQuip, the largest provider of surgical and implant management solutions in the country, has announced an agreement with Blue Cross and Blue Shield of New Mexico to provide specialized implant surgical management services to BCBSNM's membership statewide, according to…
MedBridge, a leading ambulatory surgery center development and management company, has announced several changes to its management team.
George Violin, MD, is an ophthalmologist with Medical Eye Care Associates in Norwood, Mass. He is also a co-founder and owner of Ambulatory Surgery Centers of America, an ASC management and development firm that owns interests in 34 ASCs.
Denied claims slow reimbursements endanger profitability and are a window into the integrity of the processes and workflow of surgery centers. Here, Bill Gilbert and Brice Voithofer of AdvantEdge Healthcare Solutions discuss seven reasons for claim denials in surgery centers,…
Microtest Laboratories has released a management brief that discusses reusable medical device cleaning validation and testing practices in view of the FDA’s own discussions and actions around development and maintenance of safe medical devices. Read the full report in Becker’s…
Researchers have concluded that an educational video that includes information on the entire operation experience could boost safety and patient satisfaction, according to research published in the Journal of the American College of Surgeons. Read the full report in Becker’s…
The Institute of Medicine has proposed the FDA create a central management plan for every new drug to strengthen oversight of drugs over the entire life cycle. Read the full report in Becker’s Hospital Review on the IOM report.